HIGHLIGHTS
- What: PITAC is on the verge of entering phase 2a of the IDEAL framework, but standard operating procedures, response assessment, safety issues and monitoring strategies are lacking.
- Who: Pernille Schjødt Hansen from the University Hospital, Odense, Denmark have published the Article: Review on treatment of pleural metastasis and malignant pleural effusion with Pressurized IntraThoracic Aerosol Chemotherapy (PITAC), in the Journal: (JOURNAL)
- Future: To evaluate the treatment effect of PITAC on either MPE or PLM future studies may need to assess each entity separately.
SUMMARY
Malignant pleural effusion (MPE . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.